Skip to main content
Livermore
Livermore
ZHEN

Citigroup Inc

SEC CIK
0000831001
Latest filing
Aug 3, 2026

The latest 13F from Citigroup Inc covers Q2 2026 (filed Aug 3, 2026): 4,887 long positions worth $215.3B. The top 10 holdings make up 25.8% of the portfolio, and the largest is NVIDIA Corp (NVDA) at 5.7%. Livermore has 23 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
403
Est. +$843.3M
Added
3053
Est. +$39.7B
Reduced
1183
Est. −$11.2B
Sold out
611
Est. −$1.09B

Top 5 holdings

Share of this quarter's portfolio value

  1. NVDANVIDIA Corp
    5.7%$12.3BHistory
  2. AAPLApple Inc.
    3.4%$7.32BHistory
  3. MSFTMicrosoft Corp
    3.3%$7.11BHistory
  4. MUMicron Technology Inc
    2.8%$6.12BHistory
  5. AMZNAmazon Com Inc
    2.1%$4.55BHistory

Share of portfolio

Top 5 holdings and the other 4,882 positions, by share of portfolio value

  1. NVDA5.7%
  2. AAPL3.4%
  3. MSFT3.3%
  4. MU2.8%
  5. AMZN2.1%
  6. Other 4,882 positions82.7%

Biggest buys

New and added positions, by estimated amount bought

  1. NVDANVIDIA Corp
    +$2.29BAddedHistory
  2. TSLATesla, Inc.
    +$1.15BAddedHistory
  3. AMZNAmazon Com Inc
    +$954.2MAddedHistory
  4. MSFTMicrosoft Corp
    +$887.9MAddedHistory
  5. AAPLApple Inc.
    +$874.4MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MUMicron Technology Inc
    +1.82 pp1.0% → 2.8%History
  2. AMDAdvanced Micro Devices Inc
    +0.93 pp0.8% → 1.7%History
  3. INTCIntel Corp
    +0.56 pp0.4% → 1.0%History
  4. AMATApplied Materials Inc
    +0.43 pp0.5% → 1.0%History
  5. LRCXLam Research Corp
    +0.36 pp0.5% → 0.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. iShares Russell 2000 ETF464287655
    −$1.31BReduced
  2. BACBank of America Corp
    −$1.29BReducedHistory
  3. State Street Energy Select Sector SPDR ETF81369Y506
    −$353.6MReduced
  4. First Trust Dow Jones Internet Index Fund33733E302
    −$294.8MReduced
  5. NTAPNetApp, Inc.
    −$273.3MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. BACBank of America Corp
    −0.78 pp1.2% → 0.5%History
  2. iShares Russell 2000 ETF464287655
    −0.76 pp1.3% → 0.6%
  3. State Street Energy Select Sector SPDR ETF81369Y506
    −0.30 pp0.4% → 0.1%
  4. SPYSPDR S&P 500 ETF Trust
    −0.23 pp0.7% → 0.4%History
  5. First Trust Dow Jones Internet Index Fund33733E302
    −0.17 pp0.2% → <0.1%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$215.3B
+$58.2B (+37.0%) vs. prior quarter
Positions
4,887
−208 vs. prior quarter
Top 10 concentration
25.8%
Top 10 as share of value
Turnover
6.6%
Q2 2026, one quarter
Average holding period
20.9 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $215.3B (Q2 2026)

Q1 2021: $105.1BQ2 2021: $113.3BQ3 2021: $99.9BQ4 2021: $110.7BQ1 2022: $95.9BQ2 2022: $74.7BQ3 2022: $70.9BQ4 2022: $71.2BQ1 2023: $74.6BQ2 2023: $77.7BQ3 2023: $70.1BQ4 2023: $75.5BQ1 2024: $92.1BQ2 2024: $104.1BQ3 2024: $108.1BQ4 2024: $104.0BQ1 2025: $131.5BQ2 2025: $144.2BQ3 2025: $144.9BQ4 2025: $146.8BQ1 2026: $157.1BQ2 2026: $215.3B
Q1 2021Q2 2026
13F filings of Citigroup Inc by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 3, 20264,887$215.3BNVDAAAPLMSFTvs. Q1 2026SEC
Q1 2026May 11, 20265,095$157.1BNVDAMSFTAAPLvs. Q4 2025SEC
Q4 2025Feb 13, 20265,145$146.8BNVDASPYMSFTvs. Q3 2025SEC
Q3 2025Nov 10, 20255,184$144.9BNVDAMSFTTSLAvs. Q2 2025SEC
Q2 2025Aug 11, 20254,874$144.2BNVDAMSFTAAPLvs. Q1 2025SEC
Q1 2025May 12, 20254,740$131.5BNVDAAAPLMSFTvs. Q4 2024SEC
Q4 2024Feb 12, 20254,941$104.0BNVDAAAPLMSFTvs. Q3 2024SEC
Q3 2024Nov 12, 20244,829$108.1BNVDAAAPLMSFTvs. Q2 2024SEC
Q2 2024Aug 12, 20244,772$104.1BNVDAMSFTAAPLvs. Q1 2024SEC
Q1 2024May 10, 20244,808$92.1BMSFTNVDAAAPLvs. Q4 2023SEC
Q4 2023Feb 9, 20244,855$75.5BAAPLMSFTAMZNvs. Q3 2023SEC
Q3 2023Dec 6, 2023Amended4,879$70.1BAAPLMSFTNVDAvs. Q2 2023SEC
Q2 2023Aug 10, 20234,791$77.7BMSFTAAPLSPYvs. Q1 2023SEC
Q1 2023May 11, 20234,713$74.6BAAPLSPYMSFTvs. Q4 2022SEC
Q4 2022Feb 9, 20234,939$71.2BAAPLMSFTSPYvs. Q3 2022SEC
Q3 2022Nov 10, 20225,085$70.9BAAPLSPYInvesco QQQ Trust Series Ivs. Q2 2022SEC
Q2 2022Aug 10, 20225,531$74.7BSPYAAPLMSFTvs. Q1 2022SEC
Q1 2022May 12, 20225,594$95.9BSPYAAPLMSFTvs. Q4 2021SEC
Q4 2021Feb 10, 20225,079$110.7BSPYAAPLMSFTvs. Q3 2021SEC
Q3 2021Nov 10, 20215,038$99.9BSPYAAPLMSFTvs. Q2 2021SEC
Q2 2021Aug 10, 20215,522$113.3BSPYAAPLMSFTvs. Q1 2021SEC
Q1 2021May 13, 20215,540$105.1BSPYMSFTAAPL–SEC

13D and 13G filings

Companies where Citigroup Inc reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

2 companies, largest stake first.

Companies where Citigroup Inc owns 5% or more
CompanyLatest formStakeChangeFirst filedLatest filingFiling
SMRTSmartRent, Inc.13G/A8.30%15.7M shares+2.20 ppfrom 6.10%Feb 10, 20234 filingsNov 10, 2025SEC
PRTCYPureTech Health plc13G/A6.00%14.6M shares+0.50 ppfrom 5.50%Nov 12, 20244 filingsMay 11, 2026SEC

Latest filings

36 filings on file made by Citigroup Inc or listing it as a reporting person; the latest 20 are shown.

Schedule 13D and 13G filings by Citigroup Inc
CompanyFiled (ET)FormStakeChangeEvent dateFiling
WOLFWolfspeed, Inc.Aug 5, 202610:19 AM ET13G/A1.40%719.1K shares−5.00 ppfrom 6.40%Below 5%Jun 30, 2026SEC
PRTCYPureTech Health plcMay 11, 20263:05 PM ET13G/A6.00%14.6M shares+0.50 ppfrom 5.50%Mar 31, 2026SEC
WOLFWolfspeed, Inc.Feb 13, 20261:40 PM ET13G6.40%2.88M sharesNewDec 31, 2025SEC
SMRTSmartRent, Inc.Nov 10, 202511:08 AM ET13G/A8.30%15.7M shares+2.20 ppfrom 6.10%Sep 30, 2025SEC
PRTCYPureTech Health plcAug 11, 20251:05 PM ET13G5.50%13.2M shares+1.00 ppfrom 4.50%Jun 30, 2025SEC
NXTCNextCure, Inc.May 12, 202512:54 PM ET13G4.30%1.21M sharesNewBelow 5%Mar 31, 2025SEC
SMRTSmartRent, Inc.Feb 12, 20255:47 PM ET13G6.10%11.7M shares–Dec 31, 2024SEC
INVZInnoviz Technologies Ltd.Feb 12, 20255:34 PM ET13G/A3.70%6.12M shares–Below 5%Dec 31, 2024SEC
PRTCYPureTech Health plcFeb 12, 20255:27 PM ET13G/A4.50%10.7M shares–Below 5%Dec 31, 2024SEC
EGRXEagle Pharmaceuticals, Inc.Nov 12, 20241:24 PM ET13GOld format–New–SEC
PRTCYPureTech Health plcNov 12, 202413GOld format–New–SEC
INVZInnoviz Technologies Ltd.Nov 12, 202413G/AOld format–––SEC
BVNBuenaventura Mining Co IncApr 10, 20249:48 AM ET13G/AOld format–––SEC
BVNBuenaventura Mining Co IncFeb 12, 20249:17 AM ET13GOld format–New–SEC
INVZInnoviz Technologies Ltd.Feb 12, 202413GOld format–New–SEC
SMRTSmartRent, Inc.Feb 12, 202413GOld format–––SEC
APENApollo Endosurgery, Inc.May 8, 202311:07 AM ET13G/AOld format–––SEC
FRPTFreshpet, Inc.Mar 10, 202310:46 AM ET13G/AOld format–––SEC
FRPTFreshpet, Inc.Feb 10, 202312:17 PM ET13GOld format–New–SEC
APENApollo Endosurgery, Inc.Feb 10, 202312:11 PM ET13GOld format–New–SEC